Skip to main content
Clinical Trials/CTRI/2023/04/051277
CTRI/2023/04/051277Not yet recruitingPhase 2

A Comparative assessment of Effectiveness of Triphala Gritapana and Viddhakarma with Antioxidants Therapy in Vataja Timira (Age Related Macular Degeneration Dry type )

Dr Vaishnavi Yashwant Jugdhar0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Hazy blurred and distorted central vision ,Decreased visual acuity and pinhole vision
  • 2. Dull Macular reflex and Drusen Macular reflex in fundoscopic examination.
  • 3. ARMD with immature Cataract , with operated Cataract,or with no Cataract changes

Exclusion Criteria

  • 1. All Retinal diseases involving Macula like CSR and CME
  • 2. Uncontrolled DM and HTN
  • 3. Psychiatric disorders
  • 4. Corneal lenticular or Vitreous opacities
  • 5. HIV and HbsAg pts.
  • 6. pts with cataract grading NS2 /NS3
  • 7. Those who are ayogya for siravedha and ghrutapana

Investigators

Sponsor
Dr Vaishnavi Yashwant Jugdhar

Similar Trials